The FIELD study

Lancet. 2006 Apr 8;367(9517):1141-2; author reply 1142-3. doi: 10.1016/S0140-6736(06)68500-0.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Cardiovascular Diseases / etiology*
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Fenofibrate / adverse effects*
  • Humans
  • Hypolipidemic Agents / adverse effects*
  • Mortality
  • Risk Factors

Substances

  • Hypolipidemic Agents
  • Fenofibrate